Company: CRVO
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001437749-25-013543
Chunk: 4

Company: CervoMed Inc.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 4
---
 results of operations of the combined company will be included in the Company’s financial statements. Following the completion of the Merger, the business conducted by the Company became primarily the business conducted by EIP.

Accordingly, unless the context otherwise requires, all references in this proxy statement to (i) “CervoMed,” the “Company,” “we,” “our,” or “us,” refer to EIP for all dates and periods prior to August 16, 2023 and to the business of CervoMed Inc. for all dates and periods subsequent to (and including) August 16, 2023 and (ii) “common stock” refers to the common stock, par value $0.001 per share, of the Company, after giving effect to the Reverse Stock Split. Historical share and per share figures of EIP have been retroactively restated based upon the Exchange Ratio of 0.1151.

We have also used several other defined terms in this proxy statement, many of which are explained or defined below:

| Term                   | Definition                                                                                                                                                                                                                                                                                                               |
| 2015 Equity Plan       | CervoMed Inc. 2015 Equity Incentive Plan, as amended                                                                                                                                                                                                                                                                     |
| 2018 Equity Plan       | CervoMed Inc. 2018 Employee, Director and Consultant Equity Incentive Plan, as amended                                                                                                                                                                                                                                   |
| 2020 Notes             | the previously outstanding convertible promissory notes of EIP, dated as of December 4, 2020, as amended                                                                                                                                                                                                                 |
| 2021 Notes             | the previously outstanding convertible promissory notes of EIP, dated as of December 10, 2021, as amended                                                                                                                                                                                                                |
| 2024 Private Placement | our private placement of an aggregate of 2,532,285 units, each consisting of (i) (A) one share of common stock or (B) one Pre-Funded Warrant in lieu thereof and (ii) one Series A Warrant, for aggregate gross proceeds of up to approximately $149.4 million, announced March 28, 2024, and completed on April 1, 2024 |
| 401(k) Plan            | CervoMed Inc. 401(k) Defined Contribution Plan                                                                                                                                                                                                                                                                           |
| Alpine Rewards         | Alpine Rewards LLC, independent outside consultant to the Compensation Committee                                                                                                                                                                                                                                         |
| Annual Meeting         | the 2025 Annual Meeting of Stockholders of the Company                                                                                                                                                                                                                                                                   |
| Annual Report          |